- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 271/64 - Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
Patent holdings for IPC class C07C 271/64
Total number of patents in this class: 37
10-year publication summary
3
|
0
|
1
|
3
|
2
|
1
|
3
|
6
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Tianjin Chasesun Pharmaceutical Co., Ltd | 13 |
4 |
Zevra Therapeutics, Inc. | 99 |
4 |
Zhejiang Hisun Pharmaceutical Co., Ltd. | 278 |
3 |
Katholieke Universiteit Leuven K.u. Leuven R & D | 211 |
2 |
Korea Research Institute of Chemical Technology | 1390 |
2 |
Cosmas Therapeutics Development Inc. | 3 |
2 |
Boehringer Ingelheim International GmbH | 4648 |
1 |
PPG Industries, Inc. | 3 |
1 |
University of Florida Research Foundation, Inc. | 4026 |
1 |
Duke University | 3066 |
1 |
Alnylam Pharmaceuticals, Inc. | 1149 |
1 |
Arbor Pharmaceuticals, LLC | 69 |
1 |
Arkema France | 4154 |
1 |
Assure Tech. (Hangzhou) Co., Ltd | 67 |
1 |
Grünenthal GmbH | 569 |
1 |
Imperial Innovations Limited | 595 |
1 |
Nippon Chemiphar Co., Ltd. | 229 |
1 |
Nissan Chemical Industries, Ltd. | 1717 |
1 |
NUtech Ventures | 338 |
1 |
University of Copenhagen | 411 |
1 |
Other owners | 6 |